-
- Phase 2 trials showed the drug was safe, well tolerated and produced clinically relevant biological activity http://www.hgsi.com/belimumab.html
- Discovered: July 1994
- Developed by: Human Genome Sciences and GlaxoSmithKline
- Common uses: Treatment of lupus, rheumatoid arthritis and autoimmune diseases
- Generic name: Belimumab
- Also known as: LymphoStat-B
- Phase 3 trails approved by the FDA in October of 2006 http://www.hgsi.com/belimumab.html
- Works to suppress the B-lymphocyte stimulator, an antibody that attacks the body's healthy tissues http://www.hgsi.com/belimumab.html
-
-
Benlysta is an experimental prescription drug that controls the immune system to help lupus patients. The drug was in clinical tests as of July 20, 2009, but said to be working as intended.
-
-
Benlysta News
-
INTERVIEW - Human Genome calls hepatitis drug sleeper product
... lupus drug Benlysta, a "sleeper product" for hepatitis C could provide additional billions in future sales, a company official said on Tuesday. ... (February 09, 2010)Reuters India -
Biotech ETFs Head-To-Head
In July 2009, for example, Human Genome Sciences surged more than 450% in a week after its lupus drug Benlysta showed late-stage success in a clinical trial ... (February 09, 2010)Before It's News -
Benlysta Will Garner Sales of More Than $500 Million in 2018 in the Systemic ...
If approved, Benlysta will be the first agent to launch for systemic lupus erythematosus in more than 40 years. The Pharmacor 2010 findings from the topic ... (February 01, 2010)PR Newswire (press release) -
UK court rules HGS gene patent invalid -lawyers
L) on the development of an antibody to neutrokine-alpha, called Benlysta, or belimumab, which is currently in clinical trials for the treatment of lupus, ... (February 09, 2010)Reuters
-
-
-
Benlysta Links Powered by Google
-
Positive Long-Term Data For BENLYSTA (formerly LYMPHOSTAT-B(R)) In ...
Human Genome Sciences (HGS) has reported continuation data from a Phase II study of BENLYSTA™ (belimumab, formerly LymphoStat-B®) showing sustained improvement in patient...medicalnewstoday.com -
Lupus Drug Benlysta Effective In Phase 3 Trials
In what has been described as the first lupus drug in decades to show effectiveness in phase 3 clinical trials, the announcement that Benlysta (belimumab) outperformed placebo has ...medicalnewstoday.com -
BENLYSTA™ (belimumab, formerly LymphoStat-B®) - HGS
Human Genome Sciences is an emerging pharmaceutical company with the mission to predict, prevent, detect, treat and cure disease.hgsi.com -
Human Genome Sciences Reports Positive Long-Term Data For Benlysta ...
Human Genome Sciences Reports Positive Long-Term Data For Benlysta (Formerly Lymphostat-B) In Patients With Active Systemic Lupus Erythematosus - Drugs.com MedNewsdrugs.com
-
-
Benlysta Blogs
-
The Post and Courier - New drug may hold promise for lupus ...
Benlysta could make it on the market as early as next winter. So far, the only relief for lupus sufferers has been treatments or drugs not specifically developed for lupus, such as chemotherapy or steroids, to tamp down symptoms of ... (February 08, 2010)postandcourier.com -
News On Benlysta
You might want to invest in shares of Benlysta, the new lupus drug soon to visit a pharmacy near you. According to PRNewswire, Benlysta will garner sales of more than $500 Million in 2018 in the Systemic Lupus Erythematosus dr... (February 02, 2010)femmenoir.net -
Promising New Drug for Lupus: Benlysta
"BENLYSTA is an investigational human monoclonal antibody drug and the first in a new class of drugs called BLyS-specific inhibitors. It is being developed for the treatment of systemic lupus erythematosus (SLE) by HGS and ... (February 03, 2010)pensacoladisabilitylawyer.blogspot.com -
Belimumab/Benlysta™ Update | Surviving LUPUS
Belimumab/Benlysta™ Update. (January 29, 2010)lupusurvivor.com
-
-

view more fast facts...

